Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-09
1996-05-07
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3816
Patent
active
055146538
ABSTRACT:
A method is disclosed for blocking the SEC receptor and also inhibiting the neurotoxic effects of amyloid-.beta. protein by treating SEC receptor-bearing cells with a synthetic inhibitor peptide, e.g. peptide PB145.
REFERENCES:
patent: 5137873 (1992-08-01), Yankner
patent: 5157019 (1992-10-01), Glover et al.
patent: 5164295 (1992-11-01), Kisilevsky et al.
patent: 5175253 (1992-12-01), Fallon et al.
patent: 5187153 (1993-02-01), Cordell et al.
J. Clin. Invest., vol. 90, issued Sep. 1992, Joslin et al, "The Serpin-Enzyme Complex (SEC) Receptor . . . ", pp. 1150-1154.
Brain Research, vol. 651, issued 1994, Khalil et al, "BA.sub.4 25-35 Modulates Substance P . . . ", pp. 227-235.
Perlmutter et al., Proc. Natl. Acad. Sci. USA 87, 3753-3737 (1990).
Perlmutter et al., J. Biol. Chem. 265, 16713-16716 (1990).
Joslin et al., J. Biol. Chem. 266, 21897-21902 (1991).
Yanker et al., Science 250, 279-282 (1990).
Joslin et al., J. Biol. Chem. 266, 11282-11288 (1991).
Yanker et al., N. Engl. J. Med. 325, 1849-1857 (1991).
Shearman et al., Proc. Natl. Acad. Sci. 91, 1470-1474 (1994).
Hansen et al., J. Immunol. Meth. 119, 203-210 (1989).
Meyer Scott J.
Russel Jeffrey E.
Washington University
LandOfFree
Method of blocking the SEC receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of blocking the SEC receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of blocking the SEC receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227260